Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Dir DP until

NAV on June 19, 2024
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 899 cr
Turnover Ratio 23.30%
Expense Ratio 0.83%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: 3.16%
  • 1Y: 49.96%
  • 3M: 9.08%
  • 3Y: 18.11%
  • 6M: 19.81%
  • 5Y: 27.43%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since over 3 years)
ISIN INF277K011B8
Fund Family Tata
P/E Ratio 33.09
P/B Ratio 4.63
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 5.32
Beta 0.90
R-Squared 89.68
Info Ratio 1.14
Tracking Err 4.75
Sortino 1.384
Sharpe 0.766
Std Dev 14.235
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 2.05%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 97.95%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

This fund may declare and pay out a dividend to you on a periodic basis, but only when it has the profits to do so.

View Factsheet

-


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata